RepliCel Life Sciences Inc. (REPCF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 353.73 Thousand | 353.73 Thousand | 353.73 Thousand | 353.73 Thousand | 353.73 Thousand | 121.11 Thousand |
| Cost of Revenue | 1471.00 | - | - | - | - | - |
| Gross Profit | 352.26 Thousand | 353.73 Thousand | 353.73 Thousand | 353.73 Thousand | 353.73 Thousand | 121.11 Thousand |
| Operating Expenses | 517.09 Thousand | 1.74 Million | 2.65 Million | 1.68 Million | 3.28 Million | 2.86 Million |
| Selling, General and Administrative Expenses | 1.21 Million | 1.12 Million | 1.5 Million | 884.7 Thousand | 1.08 Million | 2.15 Million |
| Research and Development Expenses | 526.43 Thousand | 623.96 Thousand | 1.14 Million | 819.4 Thousand | 2.19 Million | 709.26 Thousand |
| Other Expenses | - | -2818.00 | -2819.00 | -22.1 Thousand | -33.28 Thousand | - |
| Cost and Expenses | 517.09 Thousand | 1.74 Million | 2.65 Million | 1.68 Million | 3.28 Million | 2.86 Million |
| Operating Income | -1.38 Million | -191.43 Thousand | -3.17 Million | -1.14 Million | -2.88 Million | -2.73 Million |
| Interest Expense | 149.1 Thousand | 6701.00 | 5528.00 | 176.08 Thousand | 141.42 Thousand | - |
| Income Tax Expense | - | 545.09 Thousand | -867.89 Thousand | 183.53 Thousand | 44.02 Thousand | -29.78 Thousand |
| Earnings before Tax | -311.73 Thousand | -743.22 Thousand | -4.07 Million | -1.58 Million | -3 Million | -2.76 Million |
| Net Income | -311.73 Thousand | -1.28 Million | -3.2 Million | -1.76 Million | -3.04 Million | -2.76 Million |
| Earnings Per Share Basic | -0.01 | -0.03 | -0.10 | -0.07 | -0.13 | -0.13 |
| Earnings Per Share Diluted | -0.01 | -0.03 | -0.10 | -0.07 | -0.13 | -0.13 |
| Weighted Average Shares Outstanding | 59.24 Million | 37.76 Million | 32.48 Million | 26.96 Million | 24.1 Million | 21.85 Million |
| Weighted Average Shares Outstanding (Diluted) | 59.24 Million | 37.76 Million | 32.48 Million | 26.96 Million | 24.1 Million | 21.85 Million |
| Gross Margin | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| EBIT Margin | -3.91 | -0.54 | -8.96 | -3.23 | -8.14 | -22.35 |
| Profit Margin | -0.88 | -3.64 | -9.06 | -4.99 | -8.62 | -22.86 |
| EBITDA | -1.38 Million | -735.68 Thousand | -3.17 Million | -1.34 Million | -2.92 Million | -2.69 Million |
| Earnings Before Tax Margin | -3.92 | -0.54 | -8.97 | -3.24 | -8.15 | -22.62 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 88.43 Thousand | 88.43 Thousand | 353.73 Thousand | 88.43 Thousand | 88.43 Thousand | 88.43 Thousand |
| Cost of Revenue | 135.00 | 135.00 | 1471.00 | 270.00 | - | 1103.00 |
| Gross Profit | 88.29 Thousand | 88.29 Thousand | 352.26 Thousand | 88.16 Thousand | 88.43 Thousand | 87.33 Thousand |
| Operating Expenses | 249.32 Thousand | 214.52 Thousand | 1.73 Million | 390.74 Thousand | 413.91 Thousand | 285.74 Thousand |
| Selling, General and Administrative Expenses | 132.4 Thousand | 119.95 Thousand | - | 254.68 Thousand | 372.36 Thousand | 209.15 Thousand |
| Research and Development Expenses | 21.59 Thousand | 94.57 Thousand | - | 136.06 Thousand | 41.55 Thousand | 79.4 Thousand |
| Other Expenses | - | - | - | - | -345.66 Thousand | -309.15 Thousand |
| Cost and Expenses | 249.32 Thousand | 214.66 Thousand | 1.73 Million | 391.01 Thousand | 413.91 Thousand | 285.74 Thousand |
| Operating Income | -65.56 Thousand | -126.23 Thousand | -1.38 Million | -302.58 Thousand | -671.15 Thousand | -506.46 Thousand |
| Interest Expense | - | 27.04 Thousand | 149.1 Thousand | 14.59 Thousand | 27.26 Thousand | 80.11 Thousand |
| Income Tax Expense | 5.00 | -3.00 | -1.00 | - | -306.08 Thousand | -309.51 Thousand |
| Earnings before Tax | -187.93 Thousand | -251.83 Thousand | -311.73 Thousand | 2.02 Million | -818.6 Thousand | -558.51 Thousand |
| Net Income | -187.93 Thousand | -251.83 Thousand | -311.73 Thousand | 2.02 Million | -818.6 Thousand | -558.15 Thousand |
| Earnings Per Share Basic | -0.00 | -0.00 | - | 0.03 | -0.01 | -0.01 |
| Earnings Per Share Diluted | -0.00 | -0.00 | - | 0.03 | -0.01 | -0.01 |
| Weighted Average Shares Outstanding | 61.43 Million | 61.42 Million | 59.24 Million | 61.42 Million | 61.42 Million | 61.42 Million |
| Weighted Average Shares Outstanding (Diluted) | 61.42 Million | 61.42 Million | 59.24 Million | 61.42 Million | 61.42 Million | 61.42 Million |
| Gross Margin | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 0.99 |
| EBIT Margin | -0.74 | -1.43 | - | -3.42 | -7.59 | -5.71 |
| Profit Margin | -2.13 | -2.85 | -0.88 | 22.94 | -9.26 | -6.31 |
| EBITDA | -65.42 Thousand | -126.09 Thousand | - | -302.31 Thousand | -671.15 Thousand | -505.36 Thousand |
| Earnings Before Tax Margin | -0.74 | -1.43 | -3.92 | -3.42 | -7.59 | -5.73 |
NVA
9824
QBR-A
KAJARIACER
ACI
2435